https://ephemerisx.com/drugs/jideytro
Jideytro (zidesamtinib): FDA approval, trials and side effects
Jideytro (zidesamtinib), Nuvalent, FDA-approved July 22, 2026: trials, results, side effects and dosing, cited to 11 FDA documents.
fda approvalside effectsjideytrozidesamtinibtrials